HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Obayashi Selected Research

Resistin

1/2006Effect of atorvastatin on in vitro expression of resistin in adipocytes and monocytes/macrophages and effect of atorvastatin treatment on serum resistin levels in patients with type 2 diabetes.
1/2004Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Obayashi Research Topics

Disease

14Type 2 Diabetes Mellitus (MODY)
01/2011 - 09/2002
9Insulin Resistance
03/2012 - 01/2004
9Endometriosis
12/2007 - 01/2002
5Genetic Predisposition to Disease (Genetic Predisposition)
12/2007 - 01/2002
3Glucose Intolerance
03/2012 - 03/2008
3Non-alcoholic Fatty Liver Disease
01/2011 - 04/2010
2Fibrosis (Cirrhosis)
01/2018 - 03/2011
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2015 - 09/2002
2Fatty Liver
01/2013 - 01/2011
2Rheumatoid Arthritis
03/2011 - 03/2007
2Hyperglycemia
01/2010 - 03/2009
2Diabetic Retinopathy (Retinopathy, Diabetic)
09/2007 - 08/2003
1Acute Lung Injury
02/2016
1Colitis
02/2016
1Infections
12/2009
1Stomach Neoplasms (Stomach Cancer)
12/2009
1Ischemia
10/2008
1Hypoxia (Hypoxemia)
10/2008
1Stomach Diseases
07/2008
1Atopic Dermatitis (Atopic Eczema)
02/2007
1Autoimmune Diseases (Autoimmune Disease)
02/2007
1Hypertension (High Blood Pressure)
12/2006
1Uterine Diseases (Endometrial Disease)
07/2006
1Adenomyosis
07/2006
1Atherosclerosis
01/2006
1Obesity
01/2004
1Vitreous Hemorrhage
08/2003

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2015 - 01/2005
4Lipoproteins (Lipoprotein)IBA
01/2013 - 04/2008
4Glucose (Dextrose)FDA LinkGeneric
03/2012 - 03/2008
4Interleukin-6 (Interleukin 6)IBA
03/2011 - 08/2003
4CytokinesIBA
12/2009 - 08/2004
3Fatty Acids (Saturated Fatty Acids)IBA
01/2013 - 11/2010
3oxidized low density lipoproteinIBA
01/2013 - 01/2010
3Insulin (Novolin)FDA Link
03/2012 - 07/2005
3nasIBA
01/2011 - 04/2010
3LipidsIBA
01/2011 - 03/2008
3Biomarkers (Surrogate Marker)IBA
07/2008 - 12/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2007 - 05/2004
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2018 - 02/2016
2gluconolactonaseIBA
01/2015 - 03/2012
2Messenger RNA (mRNA)IBA
01/2013 - 07/2008
2Ezetimibe (Zetia)FDA Link
01/2011 - 11/2010
2LDL Lipoproteins (beta Lipoproteins)IBA
04/2010 - 04/2008
2AdiponectinIBA
01/2010 - 12/2006
2HLA Antigens (Human Leukocyte Antigens)IBA
12/2009 - 02/2003
2Brain-Derived Neurotrophic Factor (BDNF)IBA
07/2008 - 02/2007
2Retinaldehyde (Retinal)IBA
09/2007 - 08/2003
2pentosidineIBA
09/2007 - 08/2003
2Advanced Glycation End ProductsIBA
09/2007 - 08/2003
2ResistinIBA
01/2006 - 01/2004
2AntibodiesIBA
07/2005 - 01/2004
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
05/2004 - 02/2003
2ImmunosorbentsIBA
01/2004 - 04/2003
2EnzymesIBA
01/2004 - 04/2003
1indium-bleomycinIBA
01/2018
1Sulfonic AcidsIBA
02/2016
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
03/2012
1CholesterolIBA
01/2011
1LDL CholesterolIBA
01/2011
1Triglycerides (Triacylglycerol)IBA
01/2011
1CarbohydratesIBA
01/2011
1Pharmaceutical PreparationsIBA
01/2011
1palmitoleic acidIBA
11/2010
1Cholesterol Esters (Cholesteryl Esters)IBA
11/2010
1PalmitatesIBA
11/2010
1Collagen Type IV (Type IV Collagen)IBA
04/2010
1Pioglitazone (Actos)FDA Link
01/2010
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2010
1Metformin (Glucophage)FDA LinkGeneric
01/2010
1Telmisartan (Micardis)FDA Link
03/2009
1Superoxides (Superoxide)IBA
10/2008
110,10'-dimethyl-9,9'-biacridinium (Lucigenin)IBA
10/2008
1Hemoglobins (Hemoglobin)IBA
09/2008
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
07/2008
1Glycoside Hydrolase InhibitorsIBA
04/2008
1glimepiride (Amarel)FDA LinkGeneric
04/2008
1AcarboseFDA LinkGeneric
04/2008
1HydrogenIBA
03/2008
1KIR ReceptorsIBA
12/2007
1Angiotensin Receptor AntagonistsIBA
09/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2007
1Nerve Growth Factor (NGF)IBA
02/2007
1Nerve Growth Factors (Neurotrophins)IBA
02/2007
1Losartan (Cozaar)FDA LinkGeneric
12/2006
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2006
1Estrogens (Estrogen)FDA Link
07/2006
1PPAR gammaIBA
07/2006
1Atorvastatin (Lipitor)FDA Link
01/2006
1Cysteine (L-Cysteine)FDA Link
01/2006
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
07/2005
1Immunologic Factors (Immunomodulators)IBA
01/2005
1Interleukin-4 (Interleukin 4)IBA
08/2004
1Interferon-gamma (Interferon, gamma)IBA
08/2004
1Type II Tumor Necrosis Factor ReceptorsIBA
05/2004
1Hormones (Hormone)IBA
01/2004
1Superoxide DismutaseIBA
04/2003

Therapy/Procedure

2Glycemic Control
01/2011 - 01/2008
2Therapeutics
01/2011 - 11/2010
1Aftercare (After-Treatment)
01/2011